Product and Product Group Discharges Subject to Effluent Limitations and Standards
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Business Guidance on Phthalates
Business guidance on phthalates How to limit phthalates of concern in articles? November 2013 Danish branch of EPBA, Brussels This guidance has been prepared on the initiative of the Danish EPA and organisations, DI (the Confederation of Danish Industry), the Danish Chamber of Commerce, DI ITEK (the Danish ICT and electronics federation for it, telecommunications, electronics and communication enterprises), BFE (the Danish Consumer Electronics Association), Batteriforeningen (the Danish branch of the European battery association EPBA), ITB (the Danish IT Industry Association) and FEHA (the Danish Association for Suppliers of Electrical Domestic Appliances) in a collaboration between the Danish EPA and representatives from the organisations. The guidance applies to companies marketing articles to either private or industrial users in Denmark. The target group is buyers in Danish companies that import or act as commercial agents, intermediaries or retailers, as well as foreign companies that export to Denmark. 2 Content How to limit phthalates of concern in articles? ................................................................... 4 Key to identification of articles with phthalates .................................................................. 8 Facts on phthalates ............................................................................................................................. 10 What should you ask your supplier? .......................................................................................... 11 What are the -
268 Part 522—Implantation Or Injectable Dosage Form
§ 520.2645 21 CFR Ch. I (4–1–18 Edition) (ii) Indications for use. For the control 522.82 Aminopropazine. of American foulbrood (Paenibacillus 522.84 Beta-aminopropionitrile. larvae). 522.88 Amoxicillin. 522.90 Ampicillin injectable dosage forms. (iii) Limitations. The drug should be 522.90a Ampicillin trihydrate suspension. fed early in the spring or fall and con- 522.90b Ampicillin trihydrate powder for in- sumed by the bees before the main jection. honey flow begins, to avoid contamina- 522.90c Ampicillin sodium. tion of production honey. Complete 522.144 Arsenamide. treatments at least 4 weeks before 522.147 Atipamezole. main honey flow. 522.150 Azaperone. 522.161 Betamethasone. [40 FR 13838, Mar. 27, 1975, as amended at 50 522.163 Betamethasone dipropionate and FR 49841, Dec. 5, 1985; 59 FR 14365, Mar. 28, betamethasone sodium phosphate aque- 1994; 62 FR 39443, July 23, 1997; 68 FR 24879, ous suspension. May 9, 2003; 70 FR 69439, Nov. 16, 2005; 73 FR 522.167 Betamethasone sodium phosphate 76946, Dec. 18, 2008; 75 FR 76259, Dec. 8, 2010; and betamethasone acetate. 76 FR 59024, Sept. 23, 2011; 77 FR 29217, May 522.204 Boldenone. 17, 2012; 79 FR 37620, July 2, 2014; 79 FR 53136, 522.224 Bupivacaine. Sept. 8, 2014; 79 FR 64116, Oct. 28, 2014; 80 FR 522.230 Buprenorphine. 34278, June 16, 2015; 81 FR 48702, July 26, 2016] 522.234 Butamisole. 522.246 Butorphanol. § 520.2645 Tylvalosin. 522.275 N-Butylscopolammonium. 522.300 Carfentanil. (a) Specifications. Granules containing 522.304 Carprofen. 62.5 percent tylvalosin (w/w) as 522.311 Cefovecin. -
Review Article
REVIEW ARTICLE COLLAGEN METABOLISM COLLAGEN METABOLISM Types of Collagen 228 Structure of Collagen Molecules 230 Synthesis and Processing of Procollagen Polypeptides 232 Transcription and Translation 233 Posttranslational Modifications 233 Extracellular Processing of Procollagen and Collagen Fibrillogenesis 240 Functions of Collagen in Connective rissue 243 Collagen Degradation 245 Regulation of the Metabolism of Collagen 246 Heritable Diseases of Collagen 247 Recessive Dermatosparaxis 248 Recessive Forms of EDS 251 EDS VI 251 EDS VII 252 EDS V 252 Lysyl Oxidase Deficiency in the Mouse 253 X-Linked Cutis Laxa 253 Menke's Kinky Hair Syndrome 253 Homocystinuria 254 EDS IV 254 Dominant Forms of EDS 254 Dominant Collagen Packing Defect I 255 Dominant and Recessive Forms of Osteogenesis Imperfecta 258 Dominant and Recessive Forms of Cutis Laxa 258 The Marfan Syndrome 259 Acquired Diseases and Repair Processes Affecting Collagen 259 Acquired Changes in the Types of Collagen Synthesis 260 Acquired Changes in Amounts of Collagen Synthesized 263 Acquired Changes in Hydroxylation of Proline and Lysine 264 Acquired Changes in Collagen Cross-Links 265 Acquired Defects in Collagen Degradation 267 Conclusion 267 Bibliography 267 Collagen Metabolism A Comparison of Diseases of Collagen and Diseases Affecting Collagen Ronald R. Minor, VMD, PhD COLLAGEN CONSTITUTES approximately one third of the body's total protein, and changes in synthesis and/or degradation of colla- gen occur in nearly every disease process. There are also a number of newly described specific diseases of collagen in both man and domestic animals. Thus, an understanding of the synthesis, deposition, and turnover of collagen is important for the pathologist, the clinician, and the basic scientist alike. -
Hazardous Substances in Plastic Materials
TA Hazardous substances in plastic 3017 materials 2013 Prepared by COWI in cooperation with Danish Technological Institute Preface This report is developed within the project of mapping of prioritized hazardous substances in plastic materials. The report presents key information on the most used plastic types and their characteristics and uses, as well as on hazardous substances used in plastics and present on the Norwegian Priority List of hazardous substances (“Prioritetslisten”) and/or the Candidate List under REACH, by August 2012. The aim of the report is to be a brief handbook on plastic types and hazardous substances in plastics providing knowledge on the characteristics and use of different plastic materials and the function, uses, concentration, release patterns, and alternatives of the hazardous substances, allowing the user to use the report as an introduction and overview on the most important hazardous substances in plastics and the plastic types, they primarily are used in. The development of the report has been supervised by a steering committee consisting of: Inger-Grethe England, Klima- og Forurensningsdirektoratet (chairman) Pia Linda Sørensen, Klima- og Forurensningsdirektoratet Erik Hansen, COWI, Denmark Nils H. Nilsson, Danish Technological Institute The report has been prepared by Erik Hansen, COWI-Denmark, Nils H. Nilsson, Danish Technological Institute, Delilah Lithner, COWI-Sweden and Carsten Lassen COWI- Denmark. Vejle, Denmark, 15. January 2013 Erik Hansen, COWI (project manager) 1 Content English Summary and -
Catalytic Asymmetric Addition of Diorganozinc Reagents to N
Catalytic asymmetric addition of diorganozinc SPECIAL FEATURE reagents to N-phosphinoylalkylimines Alexandre Coˆ te´ , Alessandro A. Boezio, and Andre´ B. Charette* Department of Chemistry, University of Montreal, P.O. Box 6128, Station Downtown, Montreal, QC, Canada H3C 3J7 Edited by Jack Halpern, University of Chicago, Chicago, IL, and approved February 4, 2004 (received for review October 31, 2003) The synthesis of ␣-chiral amines bearing two alkyl groups has been hampered by the accessibility and stability of the alkylimine precursor. Herein, we report an efficient strategy to generate the alkyl-substituted imine in situ that is compatible with the Me- DuPHOS monoxide⅐Cu(I) catalyzed addition of diorganozinc re- agents. The sulfinic acid adduct of the imine is readily prepared by mixing diphenylphosphinic amide, the aldehyde, and sulfinic acid. The sulfinic acid adduct is generally isolated by filtration. The addition of diorganozinc reagents in the presence of Me-DuPHOS monoxide⅐Cu(I) and the in situ-generated imines affords the cor- Fig. 1. Bioactive ␣-chiral amines. responding ␣-chiral amines in high yields and enantiomeric excesses. sensitive imines from stable precursors has been a strategy that he synthesis of ␣-chiral amines using the catalytic asymmetric has been quite successful in a number of cases. Typically, a stable Taddition of diorganozinc reagents has produced very exciting imine adduct is used as a precursor and is converted to the imine results in recent years (1–3). This very important subunit is in situ (Scheme 2). The method involves the use of a leaving ␣ CHEMISTRY commonly found in many pharmaceuticals and other biologically group (LG) on the -carbon of the N-protected amine. -
Pyrophoric Materials
Appendix A PYROPHORIC MATERIALS Pyrophoric materials react with air, or with moisture in air. Typical reactions which occur are oxidation and hydrolysis, and the heat generated by the reactions may ignite the chemical. In some cases, these reactions liberate flammable gases which makes ignition a certainty and explosion a real possibility. Examples of pyrophoric materials are shown below. (List may not be complete) (a) Pyrophoric alkyl metals and derivatives Groups Dodecacarbonyltetracobalt Silver sulphide Dialkytzincs Dodecacarbonyltriiron Sodium disulphide Diplumbanes Hexacarbonylchromium Sodium polysulphide Trialkylaluminiums Hexacarbonylmolybdenum Sodium sulphide Trialkylbismuths Hexacarbonyltungsten Tin (II) sulphide Nonacarbonyldiiron Tin (IV) sulphide Compounds Octacarbonyldicobalt Titanium (IV) sulphide Bis-dimethylstibinyl oxide Pentacarbonyliron Uranium (IV) sulphide Bis(dimethylthallium) acetylide Tetracarbonylnickel Butyllithium (e) Pyrophoric alkyl non-metals Diethylberyllium (c) Pyrophoric metals (finely divided state) Bis-(dibutylborino) acetylene Bis-dimethylarsinyl oxide Diethylcadmium Caesium Rubidium Bis-dimethylarsinyl sulphide Diethylmagnesium Calcium Sodium Bis-trimethylsilyl oxide Diethylzinc Cerium Tantalum Dibutyl-3-methyl-3-buten-1-Yniborane Diisopropylberyllium Chromium Thorium Diethoxydimethylsilane Dimethylberyllium Cobalt Titanium Diethylmethylphosphine Dimethylbismuth chloride Hafnium Uranium Ethyldimthylphosphine Dimethylcadmium Iridium Zirconium Tetraethyldiarsine Dimethylmagnesium Iron Tetramethyldiarsine -
Chemical List
1 EXHIBIT 1 2 CHEMICAL CLASSIFICATION LIST 3 4 1. Pyrophoric Chemicals 5 1.1. Aluminum alkyls: R3Al, R2AlCl, RAlCl2 6 Examples: Et3Al, Et2AlCl, EtAlCl2, Me3Al, Diethylethoxyaluminium 7 1.2. Grignard Reagents: RMgX (R=alkyl, aryl, vinyl X=halogen) 8 1.3. Lithium Reagents: RLi (R = alkyls, aryls, vinyls) 9 Examples: Butyllithium, Isobutyllithium, sec-Butyllithium, tert-Butyllithium, 10 Ethyllithium, Isopropyllithium, Methyllithium, (Trimethylsilyl)methyllithium, 11 Phenyllithium, 2-Thienyllithium, Vinyllithium, Lithium acetylide ethylenediamine 12 complex, Lithium (trimethylsilyl)acetylide, Lithium phenylacetylide 13 1.4. Zinc Alkyl Reagents: RZnX, R2Zn 14 Examples: Et2Zn 15 1.5. Metal carbonyls: Lithium carbonyl, Nickel tetracarbonyl, Dicobalt octacarbonyl 16 1.6. Metal powders (finely divided): Bismuth, Calcium, Cobalt, Hafnium, Iron, 17 Magnesium, Titanium, Uranium, Zinc, Zirconium 18 1.7. Low Valent Metals: Titanium dichloride 19 1.8. Metal hydrides: Potassium Hydride, Sodium hydride, Lithium Aluminum Hydride, 20 Diethylaluminium hydride, Diisobutylaluminum hydride 21 1.9. Nonmetal hydrides: Arsine, Boranes, Diethylarsine, diethylphosphine, Germane, 22 Phosphine, phenylphosphine, Silane, Methanetellurol (CH3TeH) 23 1.10. Non-metal alkyls: R3B, R3P, R3As; Tributylphosphine, Dichloro(methyl)silane 24 1.11. Used hydrogenation catalysts: Raney nickel, Palladium, Platinum 25 1.12. Activated Copper fuel cell catalysts, e.g. Cu/ZnO/Al2O3 26 1.13. Finely Divided Sulfides: Iron Sulfides (FeS, FeS2, Fe3S4), and Potassium Sulfide 27 (K2S) 28 REFERRAL -
Toxicity Review of Diisobutyl Phthalate (DIBP)
identification, that is, a review of the available toxicity data for the chemical under consideration and a determination of whether the chemical is considered “toxic”. Chronic toxicity data (including carcinogenicity, neurotoxicity, and reproductive and developmental toxicity) are assessed by the CPSC staff using guidelines issued by the Commission (CPSC, 1992). If it is concluded that a substance is “toxic” due to chronic toxicity, then a quantitative assessment of exposure and risk is performed to evaluate whether the chemical may be considered a “hazardous substance”. This memo represents the first step in the risk assessment process; that is, the hazard identification step. * This report was prepared for the Commission pursuant to contract CPSC-D-06-0006. It has not been reviewed or approved by, and may not necessarily reflect the views of, the Commission. Page 2 of 2 FINAL TOXICITY REVIEW FOR DIISOBUTYL PHTHALATE (DiBP, CASRN 84-69-5) Contract No. CPSC-D-06-0006 Task Order 012 Prepared by: Versar Inc. 6850 Versar Center Springfield, VA 22151 SRC, Inc. 7502 Round Pond Road North Syracuse, NY 13212 Prepared for: Kent R. Carlson, Ph.D. U.S. Consumer Product Safety Commission 4330 East West Highway Bethesda, MD 20814 July 14, 2011 * This report was prepared for the Commission pursuant to contract CPSC-D-06-0006. It has not been reviewed or approved by, and may not necessarily reflect the views of, the Commission. TABLE OF CONTENTS TOXICITY REVIEW FOR DIISOBUTYL PHTHALATE APPENDICES .............................................................................................................................. -
CAS 84-69-5 Diisobutyl Phthalate (DIBP)
CAS 84-69-5 Diisobutyl phthalate (DIBP) Toxicity The European Union classified DIBP as a reproductive Substance of Very High Concern (SVHC).1 A 2011 study observed decreased testicular testosterone in male rats fed DIBP for 4 days.2 Borch et al. 2006 found male offspring of female rats exposed to DIBP from gestation day 7 to gestation day 20 or 21 had significantly reduced anogenital distance.3 The Chronic Hazard Advisory Panel (CHAP) determined, due to toxicological profile similarities to Dibutyl phthalate (DBP), exposure to DIBP contributes to a cumulative antiandrogenic effect with other phthalates and should be permanently banned in children’s toys and child care articles at levels greater than 0.1 percent.4 In 2017 the CPSC permanently banned DIBP in children’s toys and childcare articles at levels greater than 0.1 percent.5 Exposure The 2015 National Health and Nutrition Examination Survey (NHANES) monitored a metabolite of DIBP in human urine, and the levels appear to be increasing.6 Metabolites of DIBP were detected in the urine of pregnant Danish women in a 2010-2012 study.7 A significant correlation was found between DIBP metabolite concentrations in the urine of Danish children and increased levels of DIBP in bedroom dust and day care centers.8 Other DIBP is used as a substitute ingredient to di-n-butyl phthalate (DBP) due to structural similarities, therefore, its’ presence in products may increase.3 References 1. European Commission, Endocrine disruptor priority list. Retrieved from: http://ec.europa.eu/environment/chemicals/endocrine/strategy/substances_en.htm 2. Hannas, B.R., Lambright, C.S., Furr, J., Howdeshell, K.L., Wilson, V.S., Gray, L.E., Jr. -
Chemical Resistance of Plastics
(c) Bürkle GmbH 2010 Important Important information The tables “Chemical resistance of plastics”, “Plastics and their properties” and “Viscosity of liquids" as well as the information about chemical resistance given in the particular product descriptions have been drawn up based on information provided by various raw material manufacturers. These values are based solely on laboratory tests with raw materials. Plastic components produced from these raw materials are frequently subject to influences that cannot be recognized in laboratory tests (temperature, pressure, material stress, effects of chemicals, construction features, etc.). For this reason the values given are only to be regarded as being guidelines. In critical cases it is essential that a test is carried out first. No legal claims can be derived from this information; nor do we accept any liability for it. A knowledge of the chemical and mechanical Copyright This table has been published and updated by Bürkle GmbH, D-79415 Bad Bellingen as a work of reference. This Copyright clause must not be removed. The table may be freely passed on and copied, provided that Extensions, additions and translations If your own experiences with materials and media could be used to extend this table then we would be pleased to receive any additional information. Please send an E-Mail to [email protected]. We would also like to receive translations into other languages. Please visit our website at http://www.buerkle.de from time to Thanks Our special thanks to Franz Kass ([email protected]), who has completed and extended these lists with great enthusiasm and his excellent specialist knowledge. -
Polymer Compositions
Europaisches Patentamt European Patent Office © Publication number: 0 434 067 A2 Office europeen des brevets © EUROPEAN PATENT APPLICATION © Application number: 90124972.272.2 © int. ci.s: C08K 5/13, C08L 37/00 © Date of filing: 20.12.90 © Priority: 21.12.89 JP 334449/89 © Applicant: KURARAY Co. LTD. 1621 Sakazu Kurashiki-shi @ Date of publication of application: Okayama 710(JP) 26.06.91 Bulletin 91/26 © Inventor: Matsumoto, Mitsuo © Designated Contracting States: 1505-9, Mitzue, Kurashiki-shi DE FR GB IT NL Okayama 710(JP) Inventor: Sanda, Fumio Sun-mall Tsukumi 101, 4-21-17, Chuorinkan, Yamato-shi Kanagawa 242(JP) © Representative: Vossius & Partner Siebertstrasse 4 P.O. Box 86 07 67 W-8000 Munchen 86(DE) © Polymer compositions. © Polymer compositions comprising a polymer (A) having a repeating structure unit of the formula (I) in the main chain r R5 R8 \ (I) CM < CO o wherein Ft1, R2, R3, R+, R5 and Rs are respectively a hydrogen atom or a lower alkyl, and at least one species selected from the group consisting of a phenol compound and a plasticizer. The polymer compositions of the contained therein in CO present invention disintegrate themselves due to decomposition of the polymer (A) ft atmosphere, soil or water and thus, they are useful as materials for disposable moldings. 111 Xerox Copy Centre EP 0 434 067 A2 POLYMER COMPOSITIONS The present invention relates to polymer compositions comprising a polymer having a tetrahydrofuran skeleton, and at least one species selected from the group of a plasticizer and a phenol compound of a specific structure. -
Title Exploration of Dimethylzinc-Mediated Radical Reactions
Title Exploration of Dimethylzinc-Mediated Radical Reactions. Author(s) Yamada, Ken-Ichi; Tomioka, Kiyoshi Citation The Chemical Record (2015), 15(5): 854-871 Issue Date 2015-10 URL http://hdl.handle.net/2433/203021 This is the peer reviewed version of the following article: Yamada, K.-i. and Tomioka, K. (2015), Exploration of Dimethylzinc-Mediated Radical Reactions. Chem. Rec., 15: 854‒871, which has been published in final form at http://dx.doi.org/10.1002/tcr.201500017. This article may be used for non-commercial purposes in accordance with Wiley Right Terms and Conditions for Self-Archiving.; The full-text file will be made open to the public on 17 JUL 2016 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.; This is not the published version. Please cite only the published version.; この論文は出版社版でありません。引用の際に は出版社版をご確認ご利用ください。 Type Journal Article Textversion author Kyoto University PersonalPersonal AccountAccount THE CHEMICAL Exploration of Dimethylzinc- RECORD Mediated Radical Reactions THE CHEMICAL RECORD Ken-ichi Yamada,[a] and Kiyoshi Tomioka[b] [a] Graduate School of Pharmaceutical Sciences, Kyoto University E-mail: [email protected] [b] Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts E-mail: [email protected] Received: [will be filled in by the editorial staff] Published online: [will be filled in by the editorial staff] ABSTRACT: In this account, our studies on radical reactions that are promoted by dimethylzinc and air are described. Advantages of this reagent and differences from conventional radical initiators, such as triethylborane, are discussed. Keywords: radical reaction, dimethylzinc, C(sp3)–H bond functionalization, C–C bond formation, Umpolung Introduction It has been long time since the word "radical" changed its useful functional group transformations via a radical meaning in chemistry.